GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2026)
GeneDx Holdings (WGS) posted quarterly Non-Current Deferred Tax Liability of $1.4 million for Q1 2026, up 21.77% YoY from $1.2 million in Q1 2025, and up 85.47% sequentially from $757000.0 in Q4 2025.
GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
GeneDx Holdings has disclosed Non-Current Deferred Tax Liability across 6 years of filings, most recently posting $1.4 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 21.77% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 21.77% YoY), while the FY2025 annual figure was $757000.0, down 21.55% from the prior year.
- Non-Current Deferred Tax Liability climbed to $1.4 million in Q1 2026, from $757000.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for WGS reached as high as $56.5 million in Q4 2023 and fell as low as $747000.0 in Q2 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $1.4 million (2024), against an average of $8.1 million.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability jumped 2024.03% — and 2024, when it slumped 98.29%.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.7 million in 2022, then jumped by 2024.03% to $56.5 million in 2023, then tumbled by 98.29% to $965000.0 in 2024, then retreated by 21.55% to $757000.0 in 2025, then jumped by 85.47% to $1.4 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $1.4 million, $757000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | GeneDx Holdings | 2.10 Bn | 1.93 Bn | 68.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 757,000.00 |
| Dec 31, 2025 | 757,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 747,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 965,000.00 |
| Dec 31, 2024 | 965,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 56.48 Mn |
| Dec 31, 2023 | 56.48 Mn |